Explore

Trendline Trendline
Innovative 'Cervix-on-a-Chip' Model Advances Tissue Engineering Research

Innovative 'Cervix-on-a-Chip' Model Advances Tissue Engineering Research

Innovative 'Cervix-on-a-Chip' Model Advances Tissue Engineering Research
Rapid Read Rapid Read
Immune Cell Phenotyping Advances Understanding of Disease Biology

Immune Cell Phenotyping Advances Understanding of Disease Biology

Recent advancements in immune cell phenotyping have provided new insights into disease biology, particularly in chronic conditions. Researchers have developed methods to profile plasma membrane order across various immune cell types, revealing distinct cell states that are not detectable through traditional markers. This approach has been applied to study patients with long COVID and chronic lymphocytic leukemia, uncovering unique subsets of natural killer (NK) cells with varying cytotoxic potential and migratory capacity. These findings could lead to new therapeutic strategies and improve our understanding of immune system dysfunction.
Trendline Trendline
POP Biotechnologies Receives $9.7 Million for Vaccine Development

POP Biotechnologies Receives $9.7 Million for Vaccine Development

POP Biotechnologies Receives $9.7 Million for Vaccine Development
Trendline Trendline
Adeno-Associated Viruses: Expanding the Frontiers of Gene Therapy

Adeno-Associated Viruses: Expanding the Frontiers of Gene Therapy

Adeno-Associated Viruses: Expanding the Frontiers of Gene Therapy
Rapid Read Rapid Read
Washington University Researchers Engineer Hookworm to Deliver Antitoxin in Hosts

Washington University Researchers Engineer Hookworm to Deliver Antitoxin in Hosts

Researchers at Washington University School of Medicine in St. Louis have successfully genetically modified the human hookworm, Ancylostoma ceylanicum, to produce an antibody that neutralizes tetrodotoxin (TTX), a deadly neurotoxin. Led by Makedonka Mitreva, PhD, the team demonstrated that these modified hookworms can colonize an animal host and secrete the antitoxin into the bloodstream, partially inactivating the toxin. This breakthrough suggests a potential long-term solution for continuous treatment of chronic conditions or toxin exposure in remote areas. The study, published in Nature Communications, highlights the hookworm's ability to survive in the human gut for years, making it a viable platform for drug production and delivery.
Rapid Read Rapid Read
NASA Advances Health Research with Biotechnology on Space Station

NASA Advances Health Research with Biotechnology on Space Station

NASA's International Space Station is conducting advanced health research, including human research, microbial analysis, and 3D bioprinting. The Expedition 74 crew is involved in studies like the CIPHER suite, which examines space-induced changes in astronauts' physical and mental health. NASA flight engineers are sequencing microbial DNA and printing cartilage tissue, aiming to advance regenerative medicine. These efforts could lead to personalized medical implants using patients' cells. The research also includes spacesuit maintenance and cargo spacecraft duties.
Trendline Trendline
NewLimit Secures $435 Million for Age-Reversal Clinical Trials

NewLimit Secures $435 Million for Age-Reversal Clinical Trials

NewLimit Secures $435 Million for Age-Reversal Clinical Trials
Trendline Trendline
Cellares and TScan Collaborate on Automated Manufacturing for TSC-101 to Enhance Patient Access

Cellares and TScan Collaborate on Automated Manufacturing for TSC-101 to Enhance Patient Access

Cellares and TScan Collaborate on Automated Manufacturing for TSC-101 to Enhance Patient Access
Trendline Trendline
NanoDetection Technology and Oligomerix Secure Licensing Agreement for Neurodegenerative Diagnostic Antibodies

NanoDetection Technology and Oligomerix Secure Licensing Agreement for Neurodegenerative Diagnostic Antibodies

NanoDetection Technology and Oligomerix Secure Licensing Agreement for Neurodegenerative Diagnostic Antibodies
Trendline Trendline
Bruker Unveils High-Resolution Mass Spectrometer at ASMS 2026, Enhancing Molecular Analysis

Bruker Unveils High-Resolution Mass Spectrometer at ASMS 2026, Enhancing Molecular Analysis

Bruker Unveils High-Resolution Mass Spectrometer at ASMS 2026, Enhancing Molecular Analysis
Trendline Trendline
SMi Systems and Luminex Collaborate on Single-Molecule Imaging Technology

SMi Systems and Luminex Collaborate on Single-Molecule Imaging Technology

SMi Systems and Luminex Collaborate on Single-Molecule Imaging Technology
Rapid Read Rapid Read
Lab-Grown Brain Cells on Chip Play 'Doom', Show Potential for AI and Medicine

Lab-Grown Brain Cells on Chip Play 'Doom', Show Potential for AI and Medicine

Researchers at Cortical Labs in Australia have successfully trained lab-grown human brain cells on a silicon chip to play the video game 'Doom'. This innovative research demonstrates the potential of these neurons to adapt to stimuli in real time and complete goal-directed learning. The brain cells, grown from stem cells, were initially trained on the simpler game 'Pong' before advancing to 'Doom'. The neurons were able to respond to the game's digital environment, which was converted into electrical signals they could understand. This research highlights the potential applications of the chip, known as CL1, in fields such as drug screening and AI-like machine learning. The CL1 chip is described as a more sustainable and powerful form of intelligence, with potential uses in robotics, healthcare, and personalized medicine.